Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.32 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.31 |
| ▸ | STAT3 | P40763 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20462217 | 0.89 | PTGS1 (0.38) | NR1H2NR1H3MAOB | |
| SCHEMBL5584067 | 0.80 | PTGS1 (0.46) | NR1H2NR1H3 | |
| SCHEMBL5584310 | 0.80 | PTGS1 (0.46) | NR1H2NR1H3 | |
| SCHEMBL5584605 | 0.80 | PTGS1 (0.46) | NR1H2NR1H3 | |
| SCHEMBL16676923 | 0.78 | TERT (0.39) | RAB9ASLC6A4STAT3HIF1A | |
| SCHEMBL16674714 | 0.72 | MEN1 (0.44) | — | |
| SCHEMBL5586971 | 0.71 | ELANE (0.44) | RAB9A | |
| SCHEMBL19154890 | 0.70 | TYMS (0.33) | NR1H2NR1H3 | |
| SCHEMBL8282748 | 0.70 | SMN1; SMN2 (0.38) | NR1H2NR1H3 | |
| SCHEMBL1320959 | 0.69 | POLB (0.45) | RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150118179-A1 | BIOCIDAL COMPOUNDS AND METHODS FOR USING SAME | UNIVERSITY OF MANITOBA (CA) | 2015-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150118179-A1 | BIOCIDAL COMPOUNDS AND METHODS FOR USING SAME | NQO2, DLAT, TYR | RAB9A 1919/4885NR1H2 4478/4885NR1H3 4261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.